BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6673031)

  • 21. Invariability of blood viscosity after cold testing in patients suffering for Raynaud's disease.
    Pola P; Savi L; Dal Lago A; Flore R; Shami J
    J Cardiovasc Surg (Torino); 1980; 21(2):211-4. PubMed ID: 7364865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement of hemorheological abnormalities in alcoholics by an oral antioxidant.
    Marotta F; Safran P; Tajiri H; Princess G; Anzulovic H; Idéo GM; Rouge A; Seal MG; Idéo G
    Hepatogastroenterology; 2001; 48(38):511-7. PubMed ID: 11379344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autonomic nervous system dysfunction in sclerodermic and primary Raynaud's phenomenon.
    Pancera P; Sansone S; Presciuttini B; Montagna L; Cerù S; Lunardi C; Lechi A
    Clin Sci (Lond); 1999 Jan; 96(1):49-57. PubMed ID: 9857106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low plasma protein nitrotyrosine levels distinguish primary Raynaud's phenomenon from scleroderma.
    Kingdon EJ; Mani AR; Frost MT; Denton CP; Powis SH; Black CM; Moore KP
    Ann Rheum Dis; 2006 Jul; 65(7):952-4. PubMed ID: 16308344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Raynaud's phenomenon and systemic diseases.
    Kallenberg CG
    Vasa Suppl; 1987; 18():15-20. PubMed ID: 3299813
    [No Abstract]   [Full Text] [Related]  

  • 26. [Raynaud's disease--Raynaud's syndrome].
    Trübestein G; Sobbe A
    Med Klin; 1974 Nov; 69(48):1990-5. PubMed ID: 4453292
    [No Abstract]   [Full Text] [Related]  

  • 27. Paroxysmal dysarthria and Raynaud's phenomenon in the tongue.
    Nielsen HV; Kristensen JK; Klemp P; Staberg B; Thomsen K
    Acta Med Scand; 1984; 216(4):431-2. PubMed ID: 6516913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated homocysteine levels in patients with Raynaud's syndrome.
    Danese S; Candelli M; Gasbarrini A
    J Rheumatol; 2000 Aug; 27(8):2051. PubMed ID: 10955356
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hyperviscosity and Raynaud's symptoms in IgG3-kappa-plasmacytoma].
    Fliege R; Ehret W; Fateh-Moghadam A; Blumenstein M; Lamerz R
    Internist (Berl); 1983 Oct; 24(10):587-90. PubMed ID: 6358110
    [No Abstract]   [Full Text] [Related]  

  • 30. [Erythrocyte aggregation indicator, hematocrit and plasma viscosity in patients with a vascular form of vibration disease].
    Turczyński B; Sroczyński J
    Med Pr; 1985; 36(3):161-6. PubMed ID: 4068986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased plasma adrenomedullin concentrations in patients with Raynaud's phenomenon.
    Letizia C; Danese C; D'Erasmo E
    J Rheumatol; 1999 Mar; 26(3):759-60. PubMed ID: 10090204
    [No Abstract]   [Full Text] [Related]  

  • 32. [Blood hyperviscosity syndromes].
    Crepaldi G; Calabrò A; Belloni M; Ongaro G; Muggeo M
    Ric Clin Lab; 1983; 13 Suppl 3():89-104. PubMed ID: 6424223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis of Raynaud's phenomenon.
    Herrick AL
    Rheumatology (Oxford); 2005 May; 44(5):587-96. PubMed ID: 15741200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular responses evoked by mild cool stimuli in primary Raynaud's disease: the role of endothelin.
    Edwards CM; Marshall JM; Pugh M
    Clin Sci (Lond); 1999 Jun; 96(6):577-88. PubMed ID: 10334963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
    Colakoğlu M; Cobankara V; Akpolat T
    Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Raynaud's phenomenon and scleroderma (author's transl)].
    Merlen JF
    Ann Cardiol Angeiol (Paris); 1980 Jun; 29(4):333-7. PubMed ID: 7447353
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hemorheological changes in retinal vein occlusions].
    Peduzzi M; Debbia A; Guerrieri F; Zirilli E; Bolzani R; Barbieri U
    Ric Clin Lab; 1985; 15 Suppl 1():321-6. PubMed ID: 4035223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of blood glucose levels on hemorheological parameters, platelet activation and aggregation in oral glucose tolerance tests.
    Koltai K; Feher G; Kesmarky G; Keszthelyi Z; Czopf L; Toth K
    Clin Hemorheol Microcirc; 2006; 35(4):517-25. PubMed ID: 17148851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reactive hyperemia in Raynaud's disease.
    Pratesi F; Corsi C; Deidda C; Nuti A
    Biochem Exp Biol; 1977; 13(3):337-9. PubMed ID: 16296018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Homocysteine concentration in primary and systemic sclerosis associated Raynaud's phenomenon.
    Marasini B; Casari S; Bestetti A; Maioli C; Cugno M; Zeni S; Turri O; Guagnellini E; Biondi ML
    J Rheumatol; 2000 Nov; 27(11):2621-3. PubMed ID: 11093443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.